P821: The use of postpartum long-acting reversible contraceptives among women with genetic conditions
Saved in:
| Main Authors: | Allyson Nevins, Roni Zemet Lazar, Katherine Abraham, Ebunoluwa Ojo, Ignatia Van Den Veyver, April Adams |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Genetics in Medicine Open |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949774425012294 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
P820: Use of aspirin prophylaxis in pregnant patients with genetic conditions
by: Katherine Abraham, et al.
Published: (2025-01-01) -
P818: Factors associated with prenatal vs postnatal genetic diagnostic testing
by: Alexandra Latham, et al.
Published: (2025-01-01) -
Long-acting reversible hormonal contraception
by: N. E. Dahan-Farkas, et al.
Published: (2016-11-01) -
Contraceptive access and use of long-acting reversible contraceptives during the COVID-19 pandemic and beyond
by: Simone Crespi, et al.
Published: (2025-07-01) -
Continuous quality improvement strategy for increasing immediate postpartum long-acting reversible contraceptive use at Jimma University Medical Center, Jimma, Ethiopia
by: Gurmesa Tura Debelew, et al.
Published: (2023-02-01)